Search

everythinglearnresearchcommunity

for

Search:↓

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Menopause affects hair and skin; more research needed for treatment.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Spironolactone most effective for hirsutism, but has side effects.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Hormonal antiandrogen therapy for acne is underused and can reduce the need for antibiotics.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

The document concludes that a thorough history, physical exam, and specific tests are crucial for diagnosing and managing hair loss effectively.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

Genetic mutations can affect female sexual development, requiring personalized medical care.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Using finasteride or dutasteride does not increase the risk of male breast cancer.